Hualan Biological Engineering (SZSE:002007) 3-Year EBITDA Growth Rate : -5.40% (As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Hualan Biological Engineering 3-Year EBITDA Growth Rate?

Hualan Biological Engineering's EBITDA per Share for the three months ended in Mar. 2025 was ¥0.21.

During the past 12 months, Hualan Biological Engineering's average EBITDA Per Share Growth Rate was -28.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -5.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -1.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 10.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Hualan Biological Engineering was 91.40% per year. The lowest was -17.30% per year. And the median was 12.35% per year.

Competitive Comparison of Hualan Biological Engineering's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Hualan Biological Engineering's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hualan Biological Engineering's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hualan Biological Engineering's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Hualan Biological Engineering's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Hualan Biological Engineering 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Hualan Biological Engineering (SZSE:002007) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Hualan Biological Engineering 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Hualan Biological Engineering's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Hualan Biological Engineering Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Engineering Inc (SZSE:002007) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Hualan Avenue, Henan Province, Xinxiang, CHN, 453003

Website

http://www.hualanbio.com

Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin and others. The vaccines products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine and other. It also offers gene products such as Monoclonal Antibody for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.

Executives

Chen Zheng Yue	Executives
Fan Bei	Directors, executives
Pan Ruo Wen	Executives
Xie Jun Min	Directors, executives
An Wen Qi	Executives
An Kang	Directors, executives
Ma Xiao Wei	Executives
Zhang Bao Xian	Executives
An Wen Jue	Director
Liu Jun	Executives
Wang Qi Ping	Directors, executives
Lv Cheng Yu	Securities Affairs Representative
Zhang Jin Gang	Independent director
Wang Li Ting	Independent director
Ma Li	Supervisors

Hualan Biological Engineering Headlines

No Headlines